Drugs Made IN America Acquisition II (DMII)

$9.88 0.00 (N/A)
Market Cap N/A
Revenue (ttm) N/A
Net Income (ttm) N/A
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin N/A
Debt to Equity Ratio N/A
Volume 79,200
Avg Vol N/A
Day's Range N/A - N/A
Shares Out N/A
Stochastic %K N/A
Beta N/A
Analysts N/A
Price Target N/A
Latest News on DMII
U.S. IPO Weekly Recap: One Small Debut As More Names Join The Pipeline

Sep 27, 2025, 12:30 AM EDT - 2 months ago

U.S. IPO Weekly Recap: One Small Debut As More Names Join The Pipeline

AEXA CBK FRMI HWEP MGN NP

Drugs Made In America Acquisition II Corp. Announces Closing of $500,000,000 Initial Public Offering

Sep 26, 2025, 4:05 PM EDT - 2 months ago

Drugs Made In America Acquisition II Corp. Announces Closing of $500,000,000 Initial Public Offering

Drugs Made In America Acquisition II Corp. Announces Pricing of $500,000,000 Initial Public Offering

Sep 25, 2025, 6:43 AM EDT - 2 months ago

Drugs Made In America Acquisition II Corp. Announces Pricing of $500,000,000 Initial Public Offering

SPAC Drugs Made In America Acquisition II files for a $500 million IPO, targeting pharmaceuticals

Jul 21, 2025, 9:02 AM EDT - 4 months ago

SPAC Drugs Made In America Acquisition II files for a $500 million IPO, targeting pharmaceuticals

Drugs Made In America Acquisition II IPO Registration Document (S-1)

Jul 18, 2025, 9:17 PM EDT - 4 months ago

Drugs Made In America Acquisition II IPO Registration Document (S-1)